These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21211628)

  • 21. Major depression: the importance of clinical characteristics and treatment response to prognosis.
    Katon W; Unützer J; Russo J
    Depress Anxiety; 2010; 27(1):19-26. PubMed ID: 19798766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual sleep beliefs and sleep disturbance following Cognitive Behavioral Therapy for major depression.
    Carney CE; Harris AL; Friedman J; Segal ZV
    Depress Anxiety; 2011 Jun; 28(6):464-70. PubMed ID: 21400641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An approach to managing depression. Defining and measuring outcomes.
    Khullar A; McIntyre RS
    Can Fam Physician; 2004 Oct; 50():1374-80. PubMed ID: 15526874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Residual symptoms after a treated major depressive disorder: a survey among private psychiatrists].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(4 Pt 1):306-12. PubMed ID: 14615700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcranial direct current stimulation in a patient with therapy-resistant major depression.
    Palm U; Keeser D; Schiller C; Fintescu Z; Reisinger E; Baghai TC; Mulert C; Padberg F
    World J Biol Psychiatry; 2009; 10(4 Pt 2):632-5. PubMed ID: 19995213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and behavior therapy in the treatment and prevention of depression.
    Hollon SD
    Depress Anxiety; 2011 Apr; 28(4):263-6. PubMed ID: 21456036
    [No Abstract]   [Full Text] [Related]  

  • 27. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy and psychotherapy of pediatric depression.
    Maalouf FT; Brent DA
    Expert Opin Pharmacother; 2010 Sep; 11(13):2129-40. PubMed ID: 20707755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International consensus statement on major depressive disorder.
    Nutt DJ; Davidson JR; Gelenberg AJ; Higuchi T; Kanba S; Karamustafalioğlu O; Papakostas GI; Sakamoto K; Terao T; Zhang M
    J Clin Psychiatry; 2010; 71 Suppl E1():e08. PubMed ID: 20371035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Residual symptoms and incomplete remission. Therapeutic aspects].
    Escande M; Fabre S
    Encephale; 1994 Jun; 20 Spec No 2():269-75. PubMed ID: 8088245
    [No Abstract]   [Full Text] [Related]  

  • 32. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
    Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
    J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of early change and their relationship to outcome and follow-up among patients with major depressive disorders.
    Lutz W; Stulz N; Köck K
    J Affect Disord; 2009 Nov; 118(1-3):60-8. PubMed ID: 19217669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation of dialectical behavior therapy skills training group for treatment-resistant depression.
    Harley R; Sprich S; Safren S; Jacobo M; Fava M
    J Nerv Ment Dis; 2008 Feb; 196(2):136-43. PubMed ID: 18277222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence.
    Judd LL; Schettler PJ; Akiskal HS; Coryell W; Leon AC; Maser JD; Solomon DA
    Arch Gen Psychiatry; 2008 Apr; 65(4):386-94. PubMed ID: 18391127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The high prevalence of bipolar spectrum disorders in young adults with recurrent depression: toward an innovative diagnostic framework.
    Smith DJ; Harrison N; Muir W; Blackwood DH
    J Affect Disord; 2005 Feb; 84(2-3):167-78. PubMed ID: 15708414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe depression: recurrence and chronicity].
    Bertschy G
    Encephale; 2009 Dec; 35 Suppl 7():S257-60. PubMed ID: 20141782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the current guidelines for depression treatment.
    Gelenberg AJ
    J Clin Psychiatry; 2010 Jul; 71(7):e15. PubMed ID: 20667285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P; Lönn SL; Overø KF
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Depressive onset episode of bipolar disorder: clinical and prognostic considerations].
    Besnier N; Fakra E; Kaladjian A; Adida M; Maurel M; Azorin JM
    Encephale; 2010 Jan; 36 Suppl 1():S18-22. PubMed ID: 20141803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.